Cite
APA Citation
Hong, D., Patel, S., Patel, M., Musni, K., Anderson, M., Cooley, S., Valamehr, B., & Chu, W. (n.d.). 380 Preliminary results of an ongoing phase I trial of FT500, a first-in-class, off-the-shelf, induced pluripotent stem cell (iPSC) derived natural killer (NK) cell therapy in advanced solid tumors. Journal for immunotherapy of cancer, 8, A405. http://access.bl.uk/ark:/81055/vdc_100144714284.0x000001